Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

624
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Disorders of Hemostasis01:24

Disorders of Hemostasis

716
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
716

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LacR and TrxB are key virulence factors involved in pneumococcal meningitis as identified by a genome-wide association study.

Communications biology·2026
Same author

Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Patients With Acute Ischemic Stroke (AIS of HEARTS).

Stroke·2026
Same author

Cerebral vascular diameter and flow irregularities due to ischemic stroke after middle cerebral artery occlusion.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.

Stroke·2026
Same author

Beating the clock: comparing the speed of anticoagulation reversal in intracerebral haemorrhage to thrombolysis for acute ischaemic stroke.

European stroke journal·2026
Same author

Clinical course and patient-reported outcomes in conservatively managed spinal cavernous malformations.

Journal of neurology·2026

Related Experiment Video

Updated: Jun 9, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K

Immunothrombosis in Acute Ischemic Stroke.

Yan Wang1,2, Inge A Mulder3,4,2, Willeke F Westendorp1,2

  • 1Department of Neurology (Y.W., W.F.W., J.M.C., D.v.d.B.), Amsterdam University Medical Center, University of Amsterdam, the Netherlands.

Stroke
|October 31, 2024
PubMed
Summary
This summary is machine-generated.

Immune cells drive immunothrombosis in ischemic stroke by promoting clot formation and thromboinflammation. Understanding these mechanisms is key for developing new stroke prevention and treatment strategies.

Keywords:
ischemic strokeplaque, atheroscleroticstrokethromboinflammationthrombosis

More Related Videos

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

9.9K

Related Experiment Videos

Last Updated: Jun 9, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

9.9K

Area of Science:

  • Neurology
  • Immunology
  • Cardiovascular Research

Background:

  • Ischemic stroke is a major cause of death and disability globally.
  • Thrombosis is central to stroke pathology, making it a key therapeutic target.
  • Emerging evidence links immune cells to stroke pathogenesis, particularly through immunothrombosis.

Purpose of the Study:

  • To review the concepts of stroke immunothrombosis and thromboinflammation.
  • To explore the role of immune cells in thrombus formation and vessel recanalization.
  • To elucidate the mechanisms of immune cell activation in ischemic stroke.

Main Methods:

  • Literature review of recent research on stroke, thrombosis, and immunology.
  • Analysis of studies investigating the interaction between immune cells and the coagulation cascade.
  • Examination of evidence from endovascular treatments and thrombus analysis.

Main Results:

  • Circulating immune cells actively contribute to thrombus formation by enhancing platelet recruitment and thrombin activation.
  • Thromboinflammation, driven by immune cells, increases atherosclerotic plaque instability.
  • Immune cell involvement impacts vessel recanalization and overall patient outcomes in ischemic stroke.

Conclusions:

  • Immune cells play a critical role in the development and progression of ischemic stroke via immunothrombosis.
  • Targeting immune cell-mediated pathways presents a promising therapeutic avenue for stroke prevention and treatment.
  • Further research into immune cell activation mechanisms is crucial for advancing stroke care.